kapihan at talakayan - ww2.fda.gov.ph kapihan - 04... · •revision to ao 56 s. 1989, licensing of...
TRANSCRIPT
![Page 1: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/1.jpg)
Republic of the Philippines Department of Health
Food and Drug Administration
KAPIHAN AT TALAKAYAN
CENTER FOR DRUG REGULATION AND RESEARCH
04 December 2014 FDA Main Building
![Page 2: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/2.jpg)
1. Organizational Structure
2. CDRR Activities
3. Advocacy on Transparency
4. Updates on Regulations
5. Regulatory Challenges
6. Commitments
7. Way Forward
Presentation Outline
2
![Page 3: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/3.jpg)
Republic of the Philippines Department of Health
Food and Drug Administration
ORGANIZATIONAL STRUCTURE
3
![Page 4: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/4.jpg)
4
![Page 5: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/5.jpg)
CENTER DIRECTOR
LICENSING AND REGISTRATION
DIVISION
Manufacturers
/ Traders
Licensing
Distributors/ Retail Outlets
Licensing
LABORATORY SUPPORT DIVISION
5
Pharma/ Human
Drug Registration
Veterinary Drug
Registration
Vaccines and
Biologicals Registration
Clinical Trial
Evaluation
PMS Section
STANDARDS DEVELOPMENT
Section
CLINICAL RESEARCH
Section
PRODUCT RESEARCH AND STANDARDS
DEVELOPMENT DIVISION
![Page 6: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/6.jpg)
CDRR MANPOWER COMPLEMENT
Total CDRR
personnel
Technical
Personnel
Non
technical
Personnel
92 63 29
6
![Page 7: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/7.jpg)
Republic of the Philippines Department of Health
Food and Drug Administration
7
CDRR ACTIVITIES
![Page 8: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/8.jpg)
17 November 2014 Opening Ceremony and Forum
JY Campos Hall A, Bayanihan Center, Pioneer St., Brgy. Kapitolyo, Pasig City
8
National Consciousness
Week against Counterfeit Medicines
![Page 9: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/9.jpg)
17 November 2014 Forum and Opening ceremony
Objectives
• Discuss the global and local perspectives on Counterfeit Medicines (International organization, local and multinational pharmaceutical industry)
• Impact of Counterfeit Medicines on Public Health Safety (Consumer and Medical Healthcare Perspectives)
• Consumer awareness: Media Roundtable and Discussion
9
![Page 10: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/10.jpg)
Media Roundtable Luncheon • 9TV
• Abante
• Business Mirror
• CNN
• DZRH
• DZXL
• IBC 13
• Light network
10
• Malaya
• Manila Times
• Net 25
• Philippine Daily Inquirer
• PNA
• Reuters
• TV5
• UNTV
![Page 11: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/11.jpg)
Media Roundtable Luncheon
11
![Page 12: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/12.jpg)
17 November 2014 Opening Ceremony on JY Campos Hall A,
Bayanihan Center, Pioneer St., Brgy. Kapitolyo, Pasig City
Insights
• There is a need to raise awareness at all levels. Maximize the use of internet and the media, engage the academe
• There should be an improved patient/ consumer/ healthcare provider/industry and regulator communication and collaboration
12
![Page 13: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/13.jpg)
18 November 2014 Seminar for Law Enforcement Groups
13
![Page 14: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/14.jpg)
18 November 2014 Seminar for Law Enforcement Groups
Objectives
• Learn the routes, pathways, sources of counterfeit medicines from international experts
• Share experiences and challenges in the enforcement and prosecution of cases of Counterfeit Medicines
• Identify the barriers in effective inter-agency collaboration
14
![Page 15: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/15.jpg)
18 November 2014 Seminar for Law Enforcement Groups
Insights
• Process of collection, monitoring, and enforcement must be streamlined
• Policy gaps and judicial platform for enforcement must be addressed and aligned
• Inter-agency collaboration must be strengthened
• Effective communication between the government agencies is a must
15
![Page 16: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/16.jpg)
19 November 2014 FDA Alabang
Highlights:
• Launch of Coalition for Safe Medicines
• Launch of Pharmaceutical Transparency through Technology
• Awarding of Poster-making Contest Winners
• Pledge of commitment from government agencies , organizations, schools
16
![Page 17: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/17.jpg)
17
Coalition for Safe Medicines
![Page 18: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/18.jpg)
Poster-making contest winners
18
![Page 19: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/19.jpg)
We recognize that there is a need…
To create an anti-counterfeit stakeholder group to spearhead and initiate action agenda towards safer medicines by acting against Substandard, Spurious, Falsely Labelled, Falsified, and Counterfeit (SSFFC) medical products.
19
![Page 20: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/20.jpg)
Pledge of commitment
20
![Page 21: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/21.jpg)
21
PNP CIDG AFFCU
PCTC IPOPhl FDA
![Page 22: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/22.jpg)
PACOP PSHP PPhA
DOH League of Pharmacists
MeTA Philippines Health Sector
Catalyst
USP PQM
Manila Pharmacists
Society 22
![Page 23: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/23.jpg)
PCPI PHAP PPMA PAPPI
23
![Page 24: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/24.jpg)
24
19 November 2014 FDA Alabang
![Page 25: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/25.jpg)
20-21 November 2014
• The FDA clusters of the DOH regional offices headed by the FROO regional cluster heads carried out activities in the respective provinces.
25
![Page 26: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/26.jpg)
Republic of the Philippines Department of Health
Food and Drug Administration
Advocacy on Transparency
26
![Page 27: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/27.jpg)
Good Regulatory Practice
• CDRR-FDA’s guidance in policy formulation
27
![Page 28: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/28.jpg)
Consultation Process
Drafting of Policies at the Center Level
↓
Small/Focus Group Discussion
↓
Review and Revision
↓
Public Consultation 28
![Page 29: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/29.jpg)
Transparency and Feedback
1. The consultation shall be recorded (media and transcription)
2. Minutes and presentations shall be provided along with all other references and materials
3. Stakeholders’ responsibility to disseminate information to others
4. Should there be a need for another consultation, FDA shall call for another meeting
5. Revised draft prior to public hearing shall be posted
29
![Page 30: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/30.jpg)
Transparency and Feedback
30
![Page 31: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/31.jpg)
Transparency Advocacy
31
![Page 32: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/32.jpg)
Transparency Advocacy
32
![Page 33: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/33.jpg)
Transparency Advocacy
33
![Page 34: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/34.jpg)
LATEST DECKING SCHEDULE
34
PRODUCT SCHEDULE
Initial AUG 2013
Monitored Release AUG 2013
Automatic Renewal OCT 2014
Renewal FEB 2014
Monitored Release Extension MAR 2014
PCPR OCT 2014
CLIDP OCT 2014
Revalidation UPDATED
Variation (RRS) JUN 2014
Variation (SLE-SC) JUN 2014
Variation (MiV-PA02) JUL 2014
Variation (MiV-N01-10) AUG 2014
Compliance JUNE 2014
PROMO UPDATED
Certification UPDATED
GLE UPDATED
Vaccine Group AUG 2014
Veterinary Group MAY 2014
![Page 35: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/35.jpg)
Republic of the Philippines Department of Health
Food and Drug Administration
UPDATES ON REGULATIONS
35
![Page 36: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/36.jpg)
• Administrative Order – 2
• FDA Circular – 8
• FDA Memorandum Circular – 3
2014 Issued Regulations
36
![Page 37: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/37.jpg)
Administrative Order No. 2014-0016 (1)
37
![Page 38: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/38.jpg)
Administrative Order No. 2014-0016
• Biosimilars Registration via ACTD
• Comparability exercises as proof of similarity instead of full clinical and non-clinical data
38
![Page 39: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/39.jpg)
Administrative Order No. 2014-0034 (2)
39
![Page 40: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/40.jpg)
Administrative Order No. 2014-0034
• Revision to AO 56 s. 1989, licensing of drug establishments
• Notable changes:
Licensing of CROs and Sponsors, institutional pharmacies
New classification/grouping of establishments (DM, DD, DS, RONPDs, CROs, Sponsors) 40
![Page 41: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/41.jpg)
Administrative Order No. 2014-0034
• Revision to AO 56 s. 1989, licensing of drug establishments
• Notable changes:
Coverage to include LGUs
Implementation of RMP reqt
IEC display reqts
Pharmacy compounding 41
![Page 42: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/42.jpg)
Administrative Order No. 2014-0034
• Revision to AO 56 s. 1989, licensing of drug establishments
• Notable changes:
Waiving of pre-opening inspection for certain establishments
Validity (2 yrs for initial, 3 yrs for renewal)
Variations 42
![Page 43: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/43.jpg)
FDA Circular No. 2014-006 (1)
43
![Page 44: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/44.jpg)
FDA Circular No. 2014-006 (1)
• Issuance of Certification for minor variations for LTO
44
![Page 45: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/45.jpg)
FDA Circular No. 2014-008 (2)
45
![Page 46: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/46.jpg)
FDA Circular No. 2014-008 (2)
• Implementation of ASEAN Variation Guidelines
• Incorporation of country specific PACs
• Issuance of certifications
• Introduction of Notification
46
![Page 47: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/47.jpg)
FDA Circular No. 2014-010 (3)
47
![Page 48: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/48.jpg)
FDA Circular No. 2014-010 (3)
• Sale and distribution of empty gelatin capsules is not allowed for drug outlets
48
![Page 49: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/49.jpg)
FDA Circular No. 2014-013 (4)
49
![Page 50: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/50.jpg)
FDA Circular No. 2014-013 (4)
• Sharing of experience from practitioners, clinicians, researchers regarding the application of stem cell therapy for corneal resurfacing with limbal stem cells
50
![Page 51: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/51.jpg)
FDA Circular No. 2014-015 (5)
51
![Page 52: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/52.jpg)
FDA Circular No. 2014-015 (5)
• Reiteration: TM products ( traditional Chinese, Ayurvedic, Homeopathic) are drugs
• Manufacturers, distributors, retailers – must secure LTO
• TM must be registered
52
![Page 53: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/53.jpg)
FDA Circular No. 2014-016 (6)
53
![Page 54: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/54.jpg)
FDA Circular No. 2014-016 (6)
• IRR for Foreign GMP Clearance and Inspection of Foreign Drug Manufacturers
• Requirement for registration of imported products
54
![Page 55: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/55.jpg)
FDA Circular No. 2014-018 and amendment (7-8)
55
![Page 56: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/56.jpg)
FDA Circular No. 2014-018 and amendment (7-8)
56
![Page 57: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/57.jpg)
FDA Circular No. 2014-018 and amendment (7-8)
• Hospital establishments manufacturing medical-grade oxygen
• LTO and CPR requirements
57
![Page 58: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/58.jpg)
FDA Memorandum Circular No. 2014-001 (1)
58
![Page 59: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/59.jpg)
FDA Memorandum Circular No. 2014-001 (1)
• Submission of e-copies of registered drug products’ dossier
59
![Page 60: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/60.jpg)
FDA Memorandum Circular No. 2014-002 (2)
60
![Page 61: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/61.jpg)
FDA Memorandum Circular No. 2014-002 (2)
• New LTO format
61
![Page 62: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/62.jpg)
FDA Memorandum Circular No. 2014-015 (3)
62
![Page 63: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/63.jpg)
FDA Memorandum Circular No. 2014-015 (3)
• Display of AMR Infomercial for outlets with audio-visual displays
63
![Page 64: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/64.jpg)
Target Regulations
64
![Page 65: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/65.jpg)
1) Revised AO on Pharmacovigilance
2) Registration of Clinical Trials
3) Labeling Requirements
4) New Registration Requirements
5) Combination Products/Kits
6) RMP on Drug Products
Target Regulations 65
![Page 66: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/66.jpg)
7) Exemption from Lot Release
8) ACTR Implementation on all Drug Products
9) Blood and Blood Products Regulation
10) Physician Samples
11) Fixed Dose Combination
12) Homeopathic Product Registration
Target Regulations 66
![Page 67: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/67.jpg)
Target Regulations
13) Compassionate Special Permit
14) Radiopharmaceuticals
15) Expedited Review of Pre-qualified Vaccines
16) Donations
17) Registration of Veterinary Drug Products
67
![Page 68: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/68.jpg)
Target Regulations
18) RMP on Drug Establishments
19) Licensing of Hospital Manufacturers (Radiopharmaceuticals and Medical Oxygen)
20) Revision of BC 8 s. 2001 (Product Recall)
21) Fees and Charges
22) Registration of Medical Oxygen
22) Compounding Pharmacy
23) Licensing of LGUs
68
![Page 69: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/69.jpg)
Republic of the Philippines Department of Health
Food and Drug Administration
69
REGULATORY CHALLENGES
![Page 70: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/70.jpg)
Challenges
1. Misalignment of HR with expected regulatory workload and output
2. Increased demand for training and advocacy given the effects of harmonization and globalization
3. Influx of imported generic medicines w/o overseas GMP audit
4. Increased demand for administrative and logistical support to operations
– Lack of resources
– Needs stronger IT infrastructure
70
![Page 71: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/71.jpg)
Major Deficiencies Encountered
Noncompliance to AO 2013-0021 (ACTD/ACTR Adoption):
• Not in ACTD/ICH-CTD Format
• Lacking Part (I, II, III, or IV)
71
![Page 72: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/72.jpg)
Other Deficiencies Encountered
Noncompliance to FMC 2013-033 and FMC 2014-001 (Conversion to E-copy), and Memorandum on E-copy submission for compliance, revalidation, and re-applications:
• Corrupted files
• Empty folders
• Failure to submit e-copy of old files
72
![Page 73: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/73.jpg)
Other Deficiencies Encountered
1. Conversion to PCPR encoded as Initial
2. MR to Initial, encoded as pure MR
3. Renewal encoded as initial
4. Amendment (change in status from For Export Only to local, labelling change) encoded as initial
5. Application of PCPR + CLIDP in 1 DTN
6. MRE encoded as MR
73
![Page 74: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/74.jpg)
Other Deficiencies Encountered
7. Encoded as MR (Initial application)
8. Encoded as Initial (MR application)
9. Wrong dosage strength
10. Wrong classification (HR but encoded as Rx)
11. Wrong pharmacologic category
74
![Page 75: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/75.jpg)
Republic of the Philippines Department of Health
Food and Drug Administration
75
COMMITMENTS
![Page 76: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/76.jpg)
Commitments
1. Update existing regulations to align with international standards and practices
2. Act on all incoming requests within the committed turn-around time
3. Intensify post-market surveillance through compliance monitoring and pharmacovigilance
4. Conduct trainings for QPIRA and licensing of establishments
76
![Page 77: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/77.jpg)
Republic of the Philippines Department of Health
Food and Drug Administration
77
WAY FORWARD
![Page 78: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/78.jpg)
1. International Collaboration • Collaboration with other DRAs (Trainings, GMP Audits, Dossier
Evaluations)
• PIC/S Accession
• PPWG/TMHS
• ICDRA
2. Work Process Improvement • Risk-based approach on drug evaluation, GMP inspection and
certification, QC testing, and PMS
• Testing facilities upgrading (lot release of imported vaccines including laboratory testing, QC testing of Biosimilars, determination of impurities and contaminants)
Way Forward 78
![Page 79: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/79.jpg)
3. Alignment with other government agencies – NCPAM
– PRC- BOP
– PDEA
– BOC
– BHFS
– NCDPC
– NEC/EPI
4. Partnerships with professional associations – Philippine Pharmaceutical Association
– Philippine Medical association
Way Forward 79
![Page 80: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/80.jpg)
Conclusion
The CDRR still commits to
1. Reduce the backlog to 25% or 10% hoping for a more robust IT infrastructure and provision of more desktops or laptops
2. Given the right resources, the CDRR is committed to speed up the processing of applications
3. Continue working on the policies to provide clarity to our work process
80
![Page 81: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/81.jpg)
THANK YOU!
![Page 82: KAPIHAN AT TALAKAYAN - ww2.fda.gov.ph Kapihan - 04... · •Revision to AO 56 s. 1989, licensing of drug establishments ... 62 . FDA Memorandum Circular No. 2014-015 (3) •Display](https://reader033.vdocuments.net/reader033/viewer/2022061513/5ad3fedd7f8b9a5c638b458d/html5/thumbnails/82.jpg)